Personal Injury & Torts
Aug. 23, 2001
Hyper Critical
A disturbing lawsuit treating a scientific disagreement as an actionable tort will meet a quick, justified end if a recent Southern District of California decision is affirmed. The scientific dispute is over the existence of attention-deficit hyperactivity disorder - the only indicated use of the prescription drug Ritalin (methylphenidate) - as a medical condition.
By James M. Beck
A disturbing lawsuit treating a scientific disagreement as an actionable tort will meet a quick, justified end if a recent Southern District of California decision is affirmed. The scientific dispute is over the existence of attention-deficit hyperactivity disorder - the only indicated use of the prescription drug Ritalin (methylphenidate)...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In